https://www.selleckchem.com/products/torin-2.html
BACKGROUND Bipolar I disorder frequently has an early onset, with an estimated prevalence rate of 1.8% in pediatric populations. Early onset is associated with a high degree of chronicity; however, limited data are available on the long-term efficacy of drug therapies in pediatric populations. The aim of the current study was to evaluate the long-term safety and efficacy of lurasidone in children and adolescents with bipolar depression. METHOD Patients 10-17 years with bipolar I depression were randomized to 6 weeks of double-blind (D
Like
Comment
Share
